SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol

[1]  D. McManus,et al.  SUPPORT‐AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF , 2021, Journal of Thrombosis and Thrombolysis.

[2]  Joann L. Wagner,et al.  Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications: A Randomized Clinical Trial. , 2021, JAMA internal medicine.

[3]  D. McManus,et al.  Usability, Perceived Usefulness, and Shared Decision-Making Features of the AFib 2gether Mobile App: Protocol for a Single-Arm Intervention Study , 2021, JMIR research protocols.

[4]  J. Gagne,et al.  Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice , 2020, Annals of Internal Medicine.

[5]  Jeffrey M. Ashburner,et al.  SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation , 2020, Circulation. Cardiovascular quality and outcomes.

[6]  A. Landman,et al.  Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT). , 2019, European heart journal.

[7]  Majaz Moonis,et al.  Accuracy and Usability of a Novel Algorithm for Detection of Irregular Pulse Using a Smartwatch Among Older Adults: Observational Study , 2019, JMIR cardio.

[8]  D. Singer,et al.  Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II , 2018, JAMA cardiology.

[9]  D. McManus,et al.  SUPPORT‐AF: Piloting a Multi‐Faceted, Electronic Medical Record‐Based Intervention to Improve Prescription of Anticoagulation , 2018, Journal of the American Heart Association.

[10]  Jeffrey M. Ashburner,et al.  Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial , 2018, Journal of General Internal Medicine.

[11]  D. McIntire,et al.  Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates , 2015, Obstetrics and gynecology.

[12]  Michael F Dulin,et al.  Planning for Action: The Impact of an Asthma Action Plan Decision Support Tool Integrated into an Electronic Health Record (EHR) at a Large Health Care System , 2015, The Journal of the American Board of Family Medicine.

[13]  Jianwen Cai,et al.  Modelling recurrent events: a tutorial for analysis in epidemiology. , 2015, International journal of epidemiology.

[14]  Christoph U. Lehmann,et al.  Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example , 2015, Medical care.

[15]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[16]  D. Singer,et al.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. , 2013, The American journal of cardiology.

[17]  D. Singer,et al.  Limited English Proficient Patients and Time Spent in Therapeutic Range in a Warfarin Anticoagulation Clinic , 2013, Journal of the American Heart Association.

[18]  Timothy E. Klatt,et al.  Effect of a Best-Practice Alert on the Rate of Influenza Vaccination of Pregnant Women , 2012, Obstetrics and gynecology.

[19]  E. Newman,et al.  Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert. , 2009, Arthritis and rheumatism.

[20]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association , 2009, Circulation.

[21]  D. Gladstone,et al.  Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated , 2009, Stroke.

[22]  J. Seward,et al.  Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. , 2007, Journal of the American College of Cardiology.

[23]  Dean Schillinger,et al.  Health literacy and anticoagulation-related outcomes among patients taking warfarin , 2006, Journal of General Internal Medicine.

[24]  G. Molenberghs,et al.  Models for Discrete Longitudinal Data , 2005 .

[25]  E. Racine,et al.  Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy. , 2003, Journal of clinical nursing.

[26]  G. Lip,et al.  Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy: The West Birmingham Atrial Fibrillation Project , 2002, Stroke.

[27]  P. Ravaud,et al.  A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. , 2000, JAMA.

[28]  Hugh Calkins,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2014, Journal of the American College of Cardiology.